InsidersTradesSigma
Novonesis (Novozymes A/S): directors' dealings · Denmark · Finanstilsynet DK
DK:novonesis-novozymes-asDK0060336014DK·Finanstilsynet DKMcap 172.5Bn€Basic Materials
Explore the full management transaction log of Novonesis (Novozymes A/S), a publicly traded company based in Denmark. Shares trade on DK DK, under the supervision of Finanstilsynet DK. Operating in the Basic Materials sector, Novonesis (Novozymes A/S) has logged 175 reports. Market capitalisation: €172.5bn. The latest transaction was reported on 6 May 2021 — Purchase. Among the most active insiders: Unknown. All data is accessible without an account.
175
Insider Decl.
0
Thresholds
€731m
11 ops.
Buy Volume
€1m
28 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
370.00 €
Analyst consensus
17 analystsBuy
362.00 €Target 461.41 €(+25%)560.00 €
Income statement
Revenue4.16 Bn€
Gross profit2.24 Bn€54% margin
Net income583.6 M€14.2% margin
Valuation
PER (trailing)38.7x
PER (forward)21.2x
P/Book2.1x
Beta0.63
Balance sheet & cash
Market cap172.50 Bn€
Total debt1.80 Bn€
Free Cash Flow750.7 M€
Debt / Equity29%
Profitability & ownership
ROE5.4%
ROA3.8%
% insiders15.8%
% institutions31.4%
Last declaration on 6 May 2021
Declarations0 total
No declarations found
0 of 0 declarations
About Novonesis (Novozymes A/S)
Novonesis is a subsidiary of Novozymes A/S, focused on developing enzymatic and biological solutions. The company emphasizes sustainable innovation for various sectors, including agriculture and food.